Akums Drugs and Pharmaceuticals Limited News and Resources

Akums Drugs and Pharmaceuticals Limited has appointed Amrut Medhekar as Chief Executive Officer of its CDMO business, effective August 24, 2024. The decision was approved by the company’s Board of Directors in a recent meeting. In his new role, Medhekar

Akums Drugs and Pharmaceuticals Limited has announced its transition to a public company with an Initial Public Offer (IPO) set to open on 30 July 2024. The IPO will feature a fresh issue of equity shares amounting to INR 6,800